RegMed XB is a translational platform that currently comprises Dutch and Flemish public (universities and governments) and private (health foundations and companies) partners that aims to develop regenerative medicine (RM) solutions for patients in order to cure chronic diseases and reduce healthcare expenses. RegMed XB builds a strong RM ecosystem in which science leads to innovative products and new economic activity. The closely knitted RM ecosystem facilitates easy interactions between scientists, universities, and companies, and with the 56 million investment in the National Pilot Factory for Regenerative Medicine, RegMed XB partners and the Dutch National Growth Fund underscore the importance of solidifying the RM ecosystem further by creating an attractive environment to start new RM initiatives, collaborations, and businesses. RegMed XB has a strong interest in collaborating internationally to shorten the time to market for regenerative therapies and improve availability of these products.